Mitomycin C, vinblastine and cisplatin (MVP): an active and well-tolerated salvage regimen for advanced breast cancer

This phase II study assessed the clinical efficacy and tolerability of a combination of mitomycin C, vinblastine and cisplatin in patients with metastatic breast cancer (MBC) previously treated with chemotherapy. A total of 87 patients with MBC, most of whom had been exposed to anthracyclines (92%)...

Descripción completa

Detalles Bibliográficos
Autores principales: Urruticoechea, A, Archer, C D, Assersohn, L A, Gregory, R K, Verrill, M, Mendes, R, Walsh, G, Smith, I E, Johnston, S R D
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2005
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362079/
https://www.ncbi.nlm.nih.gov/pubmed/15685237
http://dx.doi.org/10.1038/sj.bjc.6602367

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362079/
https://www.ncbi.nlm.nih.gov/pubmed/15685237
http://dx.doi.org/10.1038/sj.bjc.6602367

Ejemplares similares